Good day, everyone, and welcome to Pfizer's Fourth Quarter 2024 Earnings ... internal medicine and inflammation and immunology. This structure fully empowers research units that can operate ...

The company also issued a 2025 guidance that fell short of expectations, as some of the company’s older drugs face ...

Just nine months after announcing a massive plan to cut costs, Bristol Myers Squibb has gone one better, revealing a new goal to save even more money.

O n Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA vaccines in humans. The bill was sponsored by State Representative Greg Kmetz ...

O n a freezing night in January, several hundred people came to Boston’s Museum of Science for a town hall-style discussion ...

In mid-2024, the commercial president of Pfizer’s oncology unit Suneet Varma announced his retirement after 15 years with the ...

Alloy Therapeutics Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...

The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

Aamir Malik; Executive Vice President, Chief US Commercial Officer; Pfizer Inc Andrew Baum; Chief Strategy and Innovation Officer, Executive Vice President; Pfizer Inc Alexandre De Germay ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...